Steve Duffy, Author at Endocrinology Advisor

Steve Duffy

Digital Content Editor

All articles by Steve Duffy

Icosapent Ethyl sNDA Submitted for Expanded Indication to Reduce Major CV Events

By

Amarin has submitted a supplemental New Drug Application (sNDA) for Vascepa (icosapent ethyl) to reduce the risk of major cardiovascular (CV) events in the statin-treated population. Icosapent ethyl is a single-molecule consisting of the omega-3 acid commonly known as EPA in ethyl-ester form. It is currently indicated as an adjunct to diet to reduce triglyceride…

Next post in General Endocrinology